Berberine with InSea2
On sale on the US market (according to the DSLD)
XYMOGEN, food supplement from the US market
Berberine with InSea2 (XYMOGEN), a food supplement au code-barres 722537511421, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 722537511421
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hypromellose, Water, Magnesium Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Chromium | Mineral | 7.5 µg |
| Berberine Hydrochloride | Other substance | 500 mg |
| Brown Seaweed Blend | Other | 250 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Berberine with InSea2
Entered into DSLD on 21 November 2020. Withdrawn from the US market on 8 September 2023 (according to the DSLD).- Active ingredient added : Ascophyllum nodosum (quantity not stated)
- Active ingredient added : Fucus vesiculosus (quantity not stated)
- Same quantity, different name: Berberine HCl in this version; Berberine Hydrochloride on the displayed label (500 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : XYMOGEN
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Berberine with InSea2 (XYMOGEN): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/722537511421-berberine-with-insea2-xymogen, updated 14 December 2023.